The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Wednesday, May 10, 2006

Pilot Study: Re-screening Adolescent and Young Adult Women for Chlamydia Infection

Lindsay Ward, Alison G. Muse, Martha Newcomb, and F. Bruce Coles. Bureau of Sexually Transmitted Disease Control, New York State Department of Health, ESP, Corning Tower Room 1168, Albany, NY, USA


Background:
The federal recommendation to re-screen women three to four months after treatment for Chlamydia was based on several studies employing a variety of methods to encourage client return.

Objective:
To assess the feasibility and effectiveness of combining multiple methods of encouraging client return on the re-screening rate of women with Chlamydia.

Method:
A prospective cross-sectional study of 15-24 year-old women attending nine Infertility Prevention Project (IPP) STD clinics and testing positive for Chlamydia from September 1 to February 28, 2006. Following informed consent, all enrollees were offered an incentive, and asked to indicate their preference for a reminder to return; M1) mail M2) telephone or M3) no reminder (unassisted). Those who returned were given a $15 gift card. Those who did not were followed-up with an additional phone call, unless the third option was chosen.

Result:
Of 1347 screened, 179 (13.3%) were infected and 70 (39%) gave informed consent. Thus far, 48 women were scheduled for re-screening. They were reminded to return using their selected method (M1=35; M2=8; M3=5). Six (12.5%) returned at the appointed time (M1=2; M2=3; M3=1). Supplemental telephone reminders were made to 27 non-returnees (M1 or M2), which resulted in an additional 7 returns, bringing the overall return rate to 27%. Of the 13 women who have returned for re-screening, only 1 (7.7%) was found to be reinfected. Data collection for re-screening is ongoing.

Conclusion:
Preliminary results indicate that a combined incentive and reminder method has not substantially enhanced return rates compared with the single option methods shown in the literature.

Implications:
The re-screening of women with Chlamydia may be difficult to implement at the clinic level, and further methods need to be developed to enhance the practicality of this recommendation.